Metabolic Factors Associated with Alanine Transaminase Levels in Non-Alcoholic Fatty Liver Disease
DOI:
https://doi.org/10.47489/szmc.v39i3.651Keywords:
Non-Alcoholic Fatty Liver Disease, NASH, Alanine Transaminase, Metabolic Syndrome, Type 2 Diabetes, Hypertension, HypertriglyceridemiaAbstract
Background: Non-Alcoholic Fatty Liver Disease is the most increasing chronic liver condition with a global prevalence of 30%. Metabolic factors like Obesity, Diabetes Mellitus are considered as major risk factors. Complications include cirrhosis and hepatocellular carcinoma. The correlation between metabolic risk factors and NAFLD is known but needs to be highlighted through contextual evidence.
Objective: To investigate the frequency of various metabolic factors and their association with Alanine Transaminase levels in patients with Non-Alcoholic Fatty Liver Disease.
Method: It was a cross-sectional study carried out over 6 months in the Liver Center and Central Diagnostic Laboratory, Mayo Hospital, Lahore in 2023-24. A sample of 124 patients ultrasonically confirmed (Moderate to severe steatosis) was recruited and LFTs, lipid profile and fasting blood sugar were measured. Data was analyzed by SPSS v26. The descriptive statistics calculated, and Pearson correlation and simple linear regression were applied.
P value of <0.05 was considered significant.
Results: Out of 124 patients, 42 (34%) were males and 82 (66%) were females. The prevalence of NAFLD with raised ALT was 61.3% and with normal ALT was 38.7%. Central obesity in NAFLD patients was 98% according to waist circumference and 57.3% according to their BMI. 45% of NAFLD patients showed the features of Metabolic Syndrome while the remaining 55% did not. Elevated ALT levels were strongly correlated with the metabolic risk factors present in NAFLD patients (p = 0.019), repeated treatment (p = 0.049) as well as treatment failure (p < 0.001).
Conclusion: Investigation of various metabolic factors in diagnosed NAFLD patients suggests that Obesity is the most common metabolic factor followed by Type 2 Diabetes and then Hypertriglyceridemia. NAFLD showed a strong correlation to raised ALT levels, present in female population more than the male. Moreover, raised ALT levels in NAFLD patients also showed a strong association with metabolic risk factors.
References
Navarroza AMC, Wong SN. Comparison of clinical and metabolic profiles of lean versus non-lean nonalcoholic fatty liver disease. Indian Journal of Gastroenterology. 2021;40(4):380-8. https://doi.org/10.1007/s12664-021- 01184-6
Lonardo A, Leoni S, Alswat KA, Fouad Y. History of Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences. 2020;21(16):5888. https://doi.org/10.3390/ijms21165888
Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-57. https://doi.org/10.1002/hep.29367
Batool S, Morton Cuthrell K, Tzenios N, Shehryar Z. Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Emerging Burden. International Research Journal of Oncology. 2022;6(4):93-104. https://journalirjo.com/index.php/IRJO/article/view/116
Wong S-W, Chan W-K. Epidemiology of non-alcoholic fatty liver disease in Asia. Indian Journal of Gastroenterology. 2020;39(1):1-8. https://doi.org/10.1007/s12664-020-01018-x
Thomas JA, Acharya S, Shukla S, Thomas JJ, Pratapa SK, Hulkoti V. Non alcoholic fatty liver disease (NAFLD) in metabolic syndrome (MetS)-A case control study. Med Sci. 2020;24(103):1490-9. https://discoveryjournals.org/medicalscience/current_issue/v24/n103/A66.pdf
Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments. Nature Reviews Gastroenterology & Hepatology. 2021;18(9):599-612. https://doi.org/10.1038/s41575-021-00448-y
Kage M, Aishima S, Kusano H, Yano H. Histopathological findings of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Journal of Medical Ultrasonics. 2020;47:549-54. https://doi.org/10.1007/s10396-020- 01061-3
Valle-Martos R, Valle M, Martos R, Cañete R, Jiménez-Reina L, Cañete MD. Liver enzymes correlate with metabolic syndrome, inflammation, and endothelial dysfunction in prepubertal children with obesity. Frontiers in Pediatrics. 2021;9:629346. https://doi.org/10.3389/fped.2021.629346
Zou Y, Zhong L, Hu C, Sheng G. Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study. Lipids in health and disease. 2020;19(1):1-10. https://doi.org/10.1186/s12944-020-01419-z
Waseem M, Saeed F, Khan R. Ultrasound Detected Non-Alcoholic Fatty Liver Disease Prevalence and its Risk Factors in Pakistani Population. Advancements in Life Sciences. 2023;9(4):607-11. https://www.als- journal.com/9433-22/
Zhou J, Zhou F, Wang W, Zhang XJ, Ji YX, Zhang P, et al. Epidemiological features of NAFLD from 1999 to 2018 in China. Hepatology. 2020;71(5):1851-64. https://doi.org/10.1002/hep.31150
Golabi P, Paik J, Hwang JP, Wang S, Lee HM, Younossi ZM. Prevalence and outcomes of non?alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States. Liver International. 2019;39(4):748-57. https://doi.org/10.1111/liv.14038
Purnell JQ. Definitions, Classification, and Epidemiology of Obesity: MDText.com, Inc., South Dartmouth (MA); 2000 2000. https://www.ncbi.nlm.nih.gov/books/NBK279167/
Prasad DS, Kabir Z, Dash AK, Das BC. Prevalence and risk factors for metabolic syndrome in Asian Indians: A community study from urban Eastern India. J Cardiovasc Dis Res. 2012;3(3):204-11. https://doi.org/10.4103/0975- 3583.98895
Powell EE, Wong VW-S, Rinella M. Non-alcoholic fatty liver disease. The Lancet. 2021;397(10290):2212-24. https://doi.org/10.1016/s0140-6736(20)32511-3
Ma X, Liu S, Zhang J, Dong M, Wang Y, Wang M, et al. Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis. BMC gastroenterology. 2020;20:1-8. https://doi.org/10.1186/s12876-020-1165-z
Nagral A, Bangar M, Menezes S, Bhatia S, Butt N, Ghosh J, et al. Gender Differences in Nonalcoholic Fatty Liver Disease. Euroasian J Hepatogastroenterol. 2022;12(Suppl 1):S19-s25. https://doi.org/10.5005/jp-journals-10018- 1370
This work is licensed under a 